Update on Investment in Neuro and Spine Associates Private Limited

Strategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹944.90

prior close

₹990.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.5%+4.5% vs market

Diversified Commercial Services peers, median of 67sector+0.2%+4.8% vs sector

On the reaction day the stock moved 4.5 pts more than Nifty Microcap 250 and 4.8 pts more than its Diversified Commercial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+0.2

15m

+0.2

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0+0.5+4.5+0.2+4.8

Next day

+4.5+0.9+3.6+0.0+4.4

+9.7+0.4+9.3+0.0+9.7

+9.7+0.5+9.2-0.1+9.8

+8.5+1.7+6.7-0.5+8.9

+7.9+2.2+5.7-0.6+8.5

+7.6+1.9+5.7+0.0+7.6

15d

+0.6-0.1+0.8-4.9+5.5

+2.6-4.2+6.8-4.1+6.7

—-1.8—-6.9—

-7.0-3.2-3.8-7.1+0.1

UpDownMarket · Nifty Microcap 250Sector · Diversified Commercial Services peers, median of 67Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Eyantra Ventures has made further progress on its investment in Neuro and Spine Associates Private Limited (NASAPL), causing NASAPL to become its subsidiary effective July 8, 2025. So far, the company has invested Rs. 10.8 crore in multiple tranches, against which NASAPL has allotted 54,000 equity shares at Rs. 2,000 each. This follows the original Board approval from September 27, 2024, which authorised investing up to Rs. 15 crore to acquire up to 75,000 shares, representing a 60% stake in NASAPL. The latest trigger was NASAPL's board allotting 5,000 additional shares on July 8, 2025, crossing the subsidiary threshold.

Likely market impact

NASAPL's financials will now be consolidated into Eyantra Ventures' results, giving shareholders direct exposure to the healthcare/neuro and spine segment. The remaining investment (up to Rs. 4.2 crore more) is still pending deployment, so further share allotments and stake build-up may continue.